Roger B. Clark
Eloxx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
RNA modifications and cancer, RNA and protein synthesis mechanisms, Toxin Mechanisms and Immunotoxins, Antibiotic Resistance in Bacteria, Chemical Synthesis and Analysis
Most-Cited Works
- → Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent(2011)124 cited
- → Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens(2021)79 cited
- → Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy(2011)72 cited
- → Synthesis and Antibacterial Activity of Pentacyclines: A Novel Class of Tetracycline Analogs(2011)62 cited
- → Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development(2013)59 cited
- → Two Novel α7 Nicotinic Acetylcholine Receptor Ligands: In Vitro Properties and Their Efficacy in Collagen-Induced Arthritis in Mice(2015)44 cited
- → 8-Azatetracyclines: Synthesis and Evaluation of a Novel Class of Tetracycline Antibacterial Agents(2011)40 cited
- → Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders(2014)33 cited
- → Solid-phase synthesis of pyrrolidines via 2-azaallyl anion cycloadditions with alkenes(1997)32 cited
- → Nonstabilized N-Unsubstituted Azomethine Ylides: A Synthesis of Indolizidine 239CD(1999)29 cited